MedPath

Effects of Continuous Nerve Block vs Single Injection Block With PCA vs PCA on Pain and Function After Knee Replacement

Not Applicable
Completed
Conditions
Pain
Interventions
Procedure: Continuous Femoral Nerve Block
Registration Number
NCT01187537
Lead Sponsor
Tan Tock Seng Hospital
Brief Summary

The purpose of this study is to compare the effectiveness of three analgesia techniques on pain relief and functional recovery after knee replacement: continuous femoral nerve block vs single-injection femoral nerve block with intravenous patient controlled analgesia vs intravenous patient controlled analgesia.

Detailed Description

Primary Outcome Measures:

* Incidence of patients with significant pain on movement on day 1 post surgery

* Range of knee flexion

Secondary Outcome Measures:

* Pain intensity (rest/movement)

* Functional recovery

* Knee Injury and Osteoarthritis Score

* Side effects/ Adverse outcomes

* SF12 Quality of Life Questionnaire

* Length of stay

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • 40 years and above
  • Osteoarthritis
  • Primary unilateral total knee replacement
  • No other lower extremity joint disease
  • ASA I-III
  • Body mass index < 35
  • No severe cardiac or pulmonary diseases
  • No chronic narcotic therapy or illicit drug use
  • Mentally competent to understand study procedures and use of pain scales
  • Able to provide informed consent
Exclusion Criteria
  • Any cause for knee replacement other than osteoarthritis
  • Total knee revision
  • Any contraindication for femoral block
  • Abnormal coagulation studies
  • Thrombocytopenia less than 100,000/cc
  • Known hepatic or renal insufficiency
  • Neurological disease involving lower extremities
  • Major surgery during the last 2 weeks pre-operatively
  • History of allergy to study medications
  • History of post-operative bleeding over 2000 cc/24 hours
  • History of opioid or alcohol abuse
  • Currently taking or has taken opioid > 30 consecutive days of daily use at a daily dose > 15mg morphine, within the past 2 weeks prior to surgery
  • Previously has not responded to opioid analgesics for treatment of pain
  • Pregnancy or breastfeeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Single-Inj Nerve Block with IV PCAContinuous Femoral Nerve Block-
Continuous Femoral Nerve BlockContinuous Femoral Nerve Block-
IV PCAContinuous Femoral Nerve Block-
Primary Outcome Measures
NameTimeMethod
Incidence of patients with significant pain on movement on day 1 post surgeryPost op day 1
Secondary Outcome Measures
NameTimeMethod
Functional recoveryDuring hospitalization, week 2, week 12

Trial Locations

Locations (1)

Tan Tock Seng Hospital

🇸🇬

Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath